Pacira Total Assets from 2010 to 2024

PCRX Stock

USD 16.80 0.70 4.00%

Pacira BioSciences, Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2008-12-31

Previous Quarter

1.6 B

Current Value

1.5 B

Quarterly Volatility

598 M

Credit Downgrade

Yuan Drop

Covid

Check Pacira BioSciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 16.1 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0014 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences, Valuation or Volatility modules.

Check out the analysis of Pacira BioSciences, Correlation against competitors.

For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Latest Pacira BioSciences,'s Total Assets Growth Pattern

Below is the plot of the Total Assets of Pacira BioSciences, over the last few years. Total assets refers to the total amount of Pacira BioSciences, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pacira BioSciences, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Pacira BioSciences,'s Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira BioSciences,'s overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.57 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Pacira Total Assets Regression Statistics

	Arithmetic Mean	797,360,820
	Geometric Mean	490,111,992
	Coefficient Of Variation	85.20
	Mean Deviation	574,060,984
	Median	628,371,000
	Standard Deviation	679,365,346
	Sample Variance	461537.3T
	Range	2B
	R-Value	0.93
	Mean Square Error	68892.9T
	R-Squared	0.86
	Slope	140,990,293
	Total Sum of Squares	6461521.8T

Pacira Total Assets History

	2024	1.7 B
	2023	1.6 B
	2022	1.7 B
	2021	2.1 B
	2020	1.3 B
	2019	831.1 M
	2018	689.4 M

Other Fundumenentals of Pacira BioSciences,

Intangibles To Total Assets

Pacira BioSciences, Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	0.22	0.95	0.32	0.58	0.97	0.96	0.36	0.92	0.86	0.44	0.94	0.63	0.95	-0.03	0.95	0.83	0.88	0.16	0.52	0.88	0.49	0.78
Total Stockholder Equity	0.96		0.22	0.91	0.38	0.6	0.93	0.98	0.39	0.79	0.76	0.25	0.9	0.64	0.97	0.05	0.98	0.81	0.88	0.11	0.33	0.91	0.61	0.88
Current Deferred Revenue	0.22	0.22		0.28	-0.34	0.35	0.24	0.14	0.7	0.23	0.44	-0.08	-0.02	0.29	0.06	0.61	0.22	0.51	0.37	0.56	0.21	0.12	0.35	0.01
Net Debt	0.95	0.91	0.28		0.3	0.61	0.96	0.9	0.45	0.88	0.81	0.3	0.88	0.6	0.88	0.02	0.91	0.84	0.85	0.35	0.41	0.9	0.43	0.73
Retained Earnings	0.32	0.38	-0.34	0.3		0.04	0.29	0.37	-0.42	0.18	-0.07	-0.02	0.51	-0.31	0.4	-0.5	0.36	-0.09	0.02	-0.24	-0.12	0.55	0.3	0.6
Accounts Payable	0.58	0.6	0.35	0.61	0.04		0.67	0.6	0.5	0.54	0.6	-0.12	0.5	0.35	0.57	0.29	0.63	0.74	0.73	0.26	0.1	0.54	0.4	0.48
Long Term Debt	0.97	0.93	0.24	0.96	0.29	0.67		0.94	0.34	0.9	0.82	0.29	0.94	0.61	0.93	-0.08	0.93	0.85	0.86	0.17	0.43	0.86	0.45	0.74
Net Receivables	0.96	0.98	0.14	0.9	0.37	0.6	0.94		0.28	0.81	0.74	0.27	0.95	0.63	0.99	-0.09	0.99	0.79	0.86	0.0	0.35	0.89	0.53	0.87
Short Term Investments	0.36	0.39	0.7	0.45	-0.42	0.5	0.34	0.28		0.32	0.58	0.0	0.04	0.54	0.23	0.88	0.34	0.66	0.58	0.73	0.14	0.29	0.41	0.11
Total Liab	0.92	0.79	0.23	0.88	0.18	0.54	0.9	0.81	0.32		0.93	0.62	0.84	0.62	0.78	-0.07	0.77	0.79	0.85	0.27	0.7	0.77	0.28	0.58
Total Current Assets	0.86	0.76	0.44	0.81	-0.07	0.6	0.82	0.74	0.58	0.93		0.59	0.69	0.72	0.71	0.26	0.72	0.87	0.9	0.36	0.7	0.65	0.42	0.49
Short Term Debt	0.44	0.25	-0.08	0.3	-0.02	-0.12	0.29	0.27	0.0	0.62	0.59		0.36	0.27	0.27	-0.11	0.18	0.18	0.31	0.03	0.86	0.19	-0.06	0.05
Intangible Assets	0.94	0.9	-0.02	0.88	0.51	0.5	0.94	0.95	0.04	0.84	0.69	0.36		0.48	0.95	-0.34	0.91	0.66	0.75	-0.09	0.39	0.87	0.42	0.82
Common Stock	0.63	0.64	0.29	0.6	-0.31	0.35	0.61	0.63	0.54	0.62	0.72	0.27	0.48		0.61	0.28	0.62	0.8	0.82	0.21	0.32	0.55	0.34	0.49
Property Plant Equipment	0.95	0.97	0.06	0.88	0.4	0.57	0.93	0.99	0.23	0.78	0.71	0.27	0.95	0.61		-0.12	0.98	0.75	0.83	-0.07	0.32	0.88	0.55	0.88
Net Tangible Assets	-0.03	0.05	0.61	0.02	-0.5	0.29	-0.08	-0.09	0.88	-0.07	0.26	-0.11	-0.34	0.28	-0.12		-0.03	0.3	0.25	0.58	-0.03	-0.05	0.34	-0.16
Good Will	0.95	0.98	0.22	0.91	0.36	0.63	0.93	0.99	0.34	0.77	0.72	0.18	0.91	0.62	0.98	-0.03		0.81	0.86	0.06	0.3	0.89	0.54	0.88
Long Term Debt Total	0.83	0.81	0.51	0.84	-0.09	0.74	0.85	0.79	0.66	0.79	0.87	0.18	0.66	0.8	0.75	0.3	0.81		0.94	0.4	0.36	0.71	0.5	0.62
Capital Surpluse	0.88	0.88	0.37	0.85	0.02	0.73	0.86	0.86	0.58	0.85	0.9	0.31	0.75	0.82	0.83	0.25	0.86	0.94		0.27	0.44	0.81	0.49	0.71
Long Term Investments	0.16	0.11	0.56	0.35	-0.24	0.26	0.17	0.0	0.73	0.27	0.36	0.03	-0.09	0.21	-0.07	0.58	0.06	0.4	0.27		0.17	0.19	-0.05	-0.13
Short Long Term Debt	0.52	0.33	0.21	0.41	-0.12	0.1	0.43	0.35	0.14	0.7	0.7	0.86	0.39	0.32	0.32	-0.03	0.3	0.36	0.44	0.17		0.22	-0.15	0.08
Net Invested Capital	0.88	0.91	0.12	0.9	0.55	0.54	0.86	0.89	0.29	0.77	0.65	0.19	0.87	0.55	0.88	-0.05	0.89	0.71	0.81	0.19	0.22		0.54	0.88
Net Working Capital	0.49	0.61	0.35	0.43	0.3	0.4	0.45	0.53	0.41	0.28	0.42	-0.06	0.42	0.34	0.55	0.34	0.54	0.5	0.49	-0.05	-0.15	0.54		0.62
Capital Stock	0.78	0.88	0.01	0.73	0.6	0.48	0.74	0.87	0.11	0.58	0.49	0.05	0.82	0.49	0.88	-0.16	0.88	0.62	0.71	-0.13	0.08	0.88	0.62

Click cells to compare fundamentals

About Pacira BioSciences, Financial Statements

Pacira BioSciences, investors use historical fundamental indicators, such as Pacira BioSciences,'s Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences,. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	1.6 B	1.7 B
Intangibles To Total Assets	0.41	0.43

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
MSFT	Microsoft

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC